9BERMUDEZ PV, SOUKI A, CANO PC, et al. Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Fredericks on type Ⅳ dyslipidemia phenotype[ J ]. Am J Ther, 2007,14 ( 2 ) : 213 - 220.
10BRUSQ J M,ANCELLIN N, GRONDIN P, et al. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine[ J]. J Lipid Res. ,2006,47(6) :1281 - 1288.